E

Exact Therapeutics AS
OSE:EXTX

Watchlist Manager
Exact Therapeutics AS
OSE:EXTX
Watchlist
Price: 2.76 NOK -8% Market Closed
Market Cap: 174.6m NOK

Relative Value

There is not enough data to reliably calculate the relative value of EXTX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EXTX Relative Value
Base Case
Not Available
E
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
-8
Median 5Y
-9.9
Industry
24.2
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-10.3
Industry
20.3
vs History
vs Industry
Median 3Y
-8
Median 5Y
-10
Industry
22.9
vs History
75
vs Industry
7
Median 3Y
6.7
Median 5Y
5.2
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-8.7
Industry
5.1
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-8.3
Industry
5.1
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-8.5
Industry
5.7
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-8.4
Industry
4.2
vs History
56
vs Industry
3
Median 3Y
4.3
Median 5Y
4
Industry
5.2

Multiples Across Competitors

EXTX Competitors Multiples
Exact Therapeutics AS Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Exact Therapeutics AS
OSE:EXTX
174.6m NOK 0 -3.3 -1.5 -1.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 750 390.3 -160 410.6 -194 789.6 -192 566.9
US
Abbvie Inc
NYSE:ABBV
336.1B USD 5.9 80.9 15.4 22.7
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD 374 305.7 -13 141.6 -13 213.5 -13 207.5
US
Amgen Inc
NASDAQ:AMGN
164.8B USD 4.8 27.8 14.8 24.4
US
Gilead Sciences Inc
NASDAQ:GILD
144.7B USD 5 24.3 10.5 14.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD 10.9 -122 26 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 087.4 -532.6 -580 -564.5
AU
CSL Ltd
ASX:CSL
129.7B AUD 5.6 31 19 23.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.9B USD 4.3 13.5 12.1 13.6
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.7 -66.5 -60
P/S Multiple
Revenue Growth P/S to Growth
NO
E
Exact Therapeutics AS
OSE:EXTX
Average P/S: 3 412 684
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 750 390.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
374 305.7
140%
2 673.6
US
Amgen Inc
NASDAQ:AMGN
4.8
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
5
3%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.9
10%
1.1
US
E
Epizyme Inc
F:EPE
2 087.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.6
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.3
4%
1.1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
P/E Multiple
Earnings Growth PEG
NO
E
Exact Therapeutics AS
OSE:EXTX
Average P/E: 35.5
Negative Multiple: -3.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 410.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.9
88%
0.9
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -13 141.6 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
27.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
24.3
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.6 N/A N/A
AU
CSL Ltd
ASX:CSL
31
16%
1.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
E
Exact Therapeutics AS
OSE:EXTX
Average EV/EBITDA: 16.3
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 789.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -13 213.5 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
14.8
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.5
6%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580 N/A N/A
AU
CSL Ltd
ASX:CSL
19
11%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.1
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
E
Exact Therapeutics AS
OSE:EXTX
Average EV/EBIT: 21
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 566.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
29%
0.8
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -13 207.5 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
24.4
32%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
14.5
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.5 N/A N/A
AU
CSL Ltd
ASX:CSL
23.7
14%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.6
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -60 N/A N/A